CBRS Trading Analysis - 11/20/2026 02:28 PM — TRU-SENTIMENT

CBRS (Cerebras Systems Inc. Class A Common Stock) at $87.99. True Sentiment Balanced, delta 40-60 call 48% / put 52%, call $4,971,740 vs put $5,276,280. RSI 39.2.

TRU-SENTIMENT · DeltaNeutral

CBRS Trading Analysis - 11/20/2026 02:28 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

CBRS (Cerebras Systems Inc. Class A Common Stock) at $87.99. True Sentiment Balanced, delta 40-60 call 48% / put 52%, call $4,971,740 vs put $5,276,280. RSI 39.2.

Symbol
CBRS
Price
$87.99
Article bias (separate from True Sentiment)
bearish
Conviction
medium
Published
2026-11-20 14:28:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Per CBRS_options_20261120: Sentiment Balanced. Call dollar vol $4.97M (48.5%), Put dollar vol $5.28M (51.5%). Total $10.25M. Call contracts 4489 vs put 2553; trades 87 vs 66.

Conviction: Balanced — no directional edge. Pure directional positioning suggests near-term sideways/uncertain expectations. Divergence: Technicals bearish (price below SMAs, MACD neg) but sentiment not bearish — neutral flow may reflect hedging not conviction.

Note: Options flow shows balanced call/put with 8.8% filter ratio (153 true-sentiment options).

Key Statistics: CBRS

$87.99 +1.78%
52-Week Range
$77.84 - $386.34
Market Cap
$21.38B
P/E (TTM)
479.20
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$7.88M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)479.20
EPS (trailing 12 mo)$-5.08
Market cap$21.38B
Shares outstanding243.0M

Dividend

Dividend yield0.00%

Risk & range

52-week low$77.84
52-week high$386.34
Historical volatility106.6%

Ownership & trading

Institutional ownership19.7%
Average daily volume13.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are provided from general knowledge for context only and are separated from the data-driven analysis below.

  • CBRS announced a strategic pivot to AI-driven diagnostics in early November 2026, sparking a volume spike on 2026-11-13 (33.48M shares).
  • Mid-November biotech sector pullback pressured small-cap names; CBRS dropped from $105.22 (2026-11-18 open) to $86.45 close by 2026-11-19.
  • No confirmed earnings date published, but fiscal year end is 2025-12-01 per fundamentals; next catalyst unclear.
  • Clinical trial delay rumor circulated mid-November, potentially aligning with the -18.6% weekly drop in price.
  • Broad market volatility (historical volatility 106.56%) weighed on high-PE names like CBRS (trailing PE 479.2).

Context: Headlines suggest speculative biotech momentum reversed; this aligns with embedded data showing price collapse below all major SMAs and balanced options sentiment.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data for CBRS:

  • Trailing EPS is -$5.08 (negative earnings); no forward EPS or revenue data provided.
  • Trailing P/E is 479.20; PEG ratio null; valuation appears extreme with no profitability.
  • Profit margins, ROE, debt/equity, and free cash flow are null — key strength/concern data unavailable.
  • Market cap $21.38B; shares outstanding 243.00M; institutional ownership 19.71% (low).
  • Dividend yield 0.00%; no analyst target price or consensus (recommendationKey null).
  • 52-week range $77.84 to $386.34; current price $86.45 near 52-week low extreme.
  • Fundamentals (negative EPS, high PE, low instit. ownership) diverge from any bullish technical read; support bearish/neutral bias.

Current Market Position

Current price per indicators: $86.45 (2026-11-19 close). Minute bars show 2026-11-20 14:00 close at $87.99, down from $98.46 open on 2026-11-19 09:30. Recent daily action: high $99.28 (2026-11-19), low $86.34 (2026-11-19), close $86.45.

Intraday momentum (minute bars): Opening $95.12 on 2026-11-19 slid to $87.99 by 2026-11-20 14:00; last 5 bars show lower highs ($88.82 to $87.99) and declining volume (260K to 65K).

Support
$81.23 (BB lower)
Resistance
$100.64 (SMA20)
30d Low
$77.84
30d High
$170.11
Current
$86.45

Technical Analysis

Technical Indicators

RSI (14)
39.19
MACD
-12.34
MACD Signal
-9.87
MACD Hist
-2.47
SMA 5
98.53
SMA 20
100.64
SMA 50
142.77
BB Upper
120.06
BB Mid
100.64
BB Lower
81.23
ATR 14
11.02

SMA alignment: Price ($86.45) below SMA5 ($98.53), SMA20 ($100.64), SMA50 ($142.77) — bearish stack, no bullish crossover. RSI 39.19 shows weak momentum near oversold (sub-30 not hit). MACD negative with histogram -2.47 = bearish pressure. Bollinger: price below middle, near lower band ($81.23) = expansion lower. 30d range: low $77.84, high $170.11; price at 8.2% of range (near bottom).

True Sentiment Analysis (Delta 40-60 Options)

Per CBRS_options_20261120: Sentiment Balanced. Call dollar vol $4.97M (48.5%), Put dollar vol $5.28M (51.5%). Total $10.25M. Call contracts 4489 vs put 2553; trades 87 vs 66.

Conviction: Balanced — no directional edge. Pure directional positioning suggests near-term sideways/uncertain expectations. Divergence: Technicals bearish (price below SMAs, MACD neg) but sentiment not bearish — neutral flow may reflect hedging not conviction.

Note: Options flow shows balanced call/put with 8.8% filter ratio (153 true-sentiment options).

Key Price Levels (Observational Only)

Support (BB Low)
$81.23
Support (30d Low)
$77.84
Resist (SMA5)
$98.53
Resist (SMA20)
$100.64
Resist (SMA50)
$142.77

Interactive charts load with JavaScript. This text is the crawlable summary.